Aurora Cannabis signs deal worth USD 3.2 billion to buy MedReleaf
Date: 2018-05-15   Author: Dhananjay Punekar  Category: #market

Aurora Cannabis signs deal worth USD 3.2 billion to buy MedReleaf

Aurora Cannabis Inc., a licensed producer of medical marijuana, has apparently decided to acquire MedReleaf, a notable medical cannabis manufacturer, for USD 3.2 billion in an all-stock bid. According to Neil Closner, CEO of MedReleaf, this is one of the biggest deals signed so far across Canada’s emerging medical cannabis sector.

In the event that the agreement receives the nod of approval, it would lead to the creation of a combined entity capable of manufacturing over 570,000 kgs of medical marijuana yearly. Reportedly, the country is likely to legalize the use of recreational marijuana and the strategy is likely to benefit both the Canada-based firms.

Analysts estimate that the combined production ability of both the firms will fulfill over two-thirds of the overall cannabis demand across the Canadian market in 2019. Terry Booth, the CEO of Aurora Cannabis, has stated that the deal will provide the firm with an opportunity to tap the expansive global medical marijuana market. A key official of MedReleaf is of the view that the firm’s acquisition by Aurora will provide the shareholders an immediate premium.

Reliable sources cite that the deal will provide USD 29.44 for each MedReleaf Share, an eighteen percent increase over its closing stock price at USD 24.90 last Friday. After the announcement of the acquisition deal, MedReleaf’s stock price increased on the Toronto Stock Exchange on Monday. The deal between the two cannabis producing giants will escalate the expansion of Canada medical marijuana industry, claim experts.

It has been speculated that the joint entity will have a market capitalization of approximately USD 7.44 billion – a figure commendably more than that of Canopy Growth Corporation, the largest licensed producer of medical cannabis in Canada.

Earlier, Aurora had also acquired CanniMed, another Canada-based medical marijuana producer, for USD 1.1 billion in an all stock & cash transaction.



About Author


Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay


Post Recommendents

Off-the-shelf Automated Workcells Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2024
Author: Partha Ray

The ' Off-the-shelf Automated Workcells market' study now available at MarketStudyReport.com, is a detailed sketch of the business sphere in terms of current and future trends driving the profit matrix. The report also indicates a pointwis...


Trends of Lab Single-mode Microplate Readers Market Reviewed for 2019 with Industry Outlook to 2024
Author: Partha Ray

The ' Lab Single-mode Microplate Readers market' research report is latest addition by Market Study Report, LLC, that elucidates relevant market and competitive insights as well as regional and consumer information. In a nutshell, the rese...


Worldwide Multi-mode Microplate Readers Market Forecast 2019-2024 Growth Drivers, Regional Outlook
Author: Partha Ray

Market Study Report, LLC, has added an exhaustive research study of the ' Multi-mode Microplate Readers market', detailing every single market driver and intricately analyzing the business vertical. This ' Multi-mode Microplate Readers...